MRX003

MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI.

It is the only "off-the-shelf" commercially available AB rated substitutable generic device opportunity for tiotropium DPI in the industry.

In February 2017, MRX003, was given the nod by the FDA as a suitable generic device with which to file a 505j ANDA of Spiriva HandiHaler (tiotropium).

Capsule DPI

Features

MRX003 Detail Shot

Get in touch with us to find out about terms of access and pricing.